Marketing & launch23 Mar 2023 01:22
I will not go into to much detail, but when i was selling Viagra for Pfizer as a medical rep,I was confronted with a mixed reception from healthcare professionals. Many were naturally sceptical ,whilst others were widely exited about offering this unique treatment to their patients. A Per-launch/post launch frenzy of articles unfolded, country by country about what this breakthrough offered. But in all the years ,the one question that many HCP asked was when was the topical treatment coming. And as we all know, in recent weeks /months only now has that alternative been forthcoming. If either Pfizer or Lilly had that range of treatments , then the landscape for ED treatment would be very different today. Historically a high percentage of patients ,do not like taking oral medication. Topical treatments always win out. From my perspective I believe that this new treatment will unfold exponentially. As we know Futura is a Minnow in comparison to the giants of the pharmaceutical industry, and they have limited resources when it comes to marketing. They will no doubt focus those resources to get the maximum return on exposure. But Gps and ED specialists will eventually point ED suffers in the direction of a topical treatment. And yes like oral Ed treatments not all patients respond. But until you try as a sufferer you will not know if this product works for you. The ED market is and always will be a huge cash cow for those in the market. There will always be millions who suffer from this disease and the potential rewards go hand in hand. Not if, but when this product goes viral around the World, the big players will take notice. They cannot allow an ED treatment (outside their portfolios ) to start eating into their market share. Also any big player who steps in, and Markets this for themselves will suddenly be at the forefront of ED treatments. Now that the product has been launched, the media in those countries will raise the noise levels . Time and patience is what is needed from shareholders. Viagra is what launched Pfizer share price all those years ago. Futura is at the beginning of that journey and we will be privileged to see it unfold in the coming months. There will be setbacks. The other companies may try to rubbish the product, in an effort to sow doubt about its efficacy . This is typical of the industry. But bad news can also be good news in upping the sound bits. There is a long and twisting road ahead, but this unique product will eventually pull through
Sign In
Follow the stocks
